Role of liraglutide on cardiotoxicity and gut microbiota changes induced by doxorubicin in rats

Back

ESC Professional Premium Access

Role of liraglutide on cardiotoxicity and gut microbiota changes induced by doxorubicin in rats

Session: Cardiovascular complications in cardio-oncology: risk assessment

Topic: Cardio-Oncology

Speaker: Doctor C. Rodrigues Tonon (Botucatu, BR)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Carolina Rodrigues Tonon

Botucatu (Brazil)

0 follower

8 more presentations in this session

The prognostic significance of Weber and ventilatory CPET classifications in amyloidosis patients

Speaker: Doctor S. Santos Patarroyo (Rochester, US) Doctor L. Ortega Aviles (Rochester, US)

Assessment of poor cardiovascular health metrics and related disparities among cancer patients in the United States: a nationwide analysis of over 1.5 million individuals

Speaker: Doctor S. Abohashem (Boston, US)

A study to assess the ability of the HFA-ICOS risk stratification tool to predict cancer therapy-related cardiac dysfunction for patients receiving anthracycline chemotherapy.

Speaker: Doctor A. Byrne (Godalming, GB)

Cardiovascular effects of BRAF and MEK inhibitors in patients with melanoma: a prospective study incorporating risk scores, cardiac biomarkers and cardiovascular magnetic resonance imaging

Speaker: Doctor C. Glen (Glasgow, GB)

Real-world analysis of transcatheter aortic valve replacement in patients with prostate cancer and severe aortic stenosis

Speaker: Doctor R. Belo Nunes (Sao Paulo, BR)

Access the full session

Cardiovascular complications in cardio-oncology: risk assessment

Speakers: Doctor C. Rodrigues Tonon, Doctor S. Santos Patarroyo, Doctor L. Ortega Aviles, Doctor S. Abohashem, Doctor A. Byrne...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources